Chinese Investors Wary Of In-Licensing-Only Biotechs After IPO Setback

 
• By Dexter Jie Yan
red flag raised for Chinese investors
Chinese exchange’s refusal of one biotech’s IPO request raises red flag to some investors. • Source: Alamy

More from China

More from Focus On Asia